Drug Type Immune cell therapy |
Synonyms ABIN 19, ABIN19 |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Abintus Bio, Inc.Startup |
Active Organization Abintus Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Preclinical | US | Abintus Bio, Inc.Startup | 03 Aug 2023 |